Interestingly, CHOP, another UPR-associated transcription factor, was found to inhibit CHAC1 transcription via the ATF/CRE element without directly binding to it
Science 381 , 466467 (2023)
Theyre used to: Lower blood sugar in type 2 diabetes Promote weight loss Improve heart health (in some cases) Examples include: Semaglutide (Ozempic, Wegovy) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) Tirzepatide (Mounjaro), technically a dual GIP/GLP-1 agonist Which GLP-1 is best for weight loss
10.1002/da.22968 2
Primary antibodies [Rabbit anti-GLP1R (#PA5-97789, Invitrogen
Future Research Priorities in Safety and Tolerability Despite the promising role of GLP-1-based therapies, several areas require further investigation to ensure their long-term safety in adolescents: Long-Term Metabolic Effects: Future studies should evaluate how sustained GLP-1RA use affects insulin sensitivity, lipid metabolism, and cardiovascular health over decades